[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351162-105":59,"doc-detail-351162-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-current-state-of-polygenic-scores-for-the-development-of-lung-cancer-a-systematic-review-and-validation-in-uk-biobank","The current state of polygenic scores for the development of lung cancer: a systematic review and validation in UK Biobank","","Risk-stratified lung cancer screening selects tobacco-exposed high-risk individuals without fully capturing underlying genetic susceptibility. This study systematically identified published lung cancer polygenic scores (PGS) and evaluated discrimination and accuracy after implementation and validation in the UK Biobank cohort. Performance differed by sex, ethnicity, and smoking status. While most PGS were associated with lung cancer risk, overall discrimination remained weaker than for other cancers, and benefits from combining genetics with additional risk factors were uncertain.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-current-state-of-polygenic-scores-for-the-development-of-lung-cancer-a-systematic-review-and-validation-in-uk-biobank/351162/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-current-state-of-polygenic-scores-for-the-development-of-lung-cancer-a-systematic-review-and-validation-in-uk-biobank/351162.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about lung cancer screening?","Question",{"text":112,"@type":113},"It evaluates whether existing lung cancer polygenic scores can identify high-risk individuals in the general population, beyond tobacco-related risk stratification.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were polygenic scores selected and validated?",{"text":117,"@type":113},"A systematic review identified published lung cancer PGS, which were implemented and validated in the UK Biobank cohort, with performance compared across scores.",{"name":119,"@type":110,"acceptedAnswer":120},"What factors affected polygenic score performance?",{"text":121,"@type":113},"Subgroup analyses showed differences across sex, ethnicity, and smoking status, with many scores performing better in tobacco users than in non-users.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351162,1790201733,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","British Journal of Cancer [www.nature.com/bjc](www.nature.com/bjc)  \nARTICLE OPEN   \nGenetics and Genomics  \nThe current state of polygenic scores for the development of lung cancer: a systematic review and validation in UK Biobank  \nBayan Galal 1, Joe Dennis 2, Antonis C. Antoniou2 and Hannah Harrison 2 ✉  \n© The Author(s) 2026  \nBACKGROUND: Risk-stratiﬁed lung cancer screening programs identify high-risk individuals who use tobacco but do not account for underlying genetic susceptibility. Many polygenic scores (PGS) have been developed for lung cancer, but it is unclear which, if any, are suitable for identifying high-risk individuals in the general population.  \nMETHODS: We used a systematic review to identify published lung cancer PGS, which were implemented and validated in the UK Biobank (UKB) cohort. Performance (discrimination and accuracy) was compared. Subgroup analyses by sex, ethnicity, and smoking status identiﬁed differences across the population.  \nRESULTS: We identiﬁed 60 lung cancer PGS published since 2012 . Most scores were associated with lung cancer risk in UKB. Of the 39 evaluated PGS, 33 had a hazard ratio per standard deviation greater than 1.1 and 22 had a C-index greater than 0.55 . Most PGS perform better in individuals who use tobacco than those who do not, although for a small number of scores (n = 8) the reverse is true.  \nDISCUSSION: Performance of lung cancer PGS is weak compared to scores for other cancers; the potential beneﬁt of combining genetics with other risk factors for lung cancer remains unclear. Selection of a suitable score is context dependent and requires consideration of the characteristics of the target population (such as ethnicity and tobacco usage) .  \nBritish Journal of Cancer (2026) 134:939–948; [https://doi.org/10.1038/s41416-025-03330-9](https://doi.org/10.1038/s41416-025-03330-9)  \nINTRODUCTION  \nLung cancer remains the leading cause of cancer-related deaths worldwide [1], in the United Kingdom (UK) there are 45,000 incident cases and 35,000 deaths annually [2] . Lung cancer is often asymptomatic in the early stages, which contributes to the high number of late stage diagnoses; in 2018, 65% of lung cancer diagnoses in the UK were either at Stage III or IV [3] . Survival rates for lung cancer vary signiﬁcantly depending on the stage at diagnosis. Approximately 5% of patients diagnosed at stage IV survive for 5 years or more after diagnosis, compared to around 65% of those diagnosed at stage I [4] .  \nScreening with low-dose computed tomography (LDCT) aims to detect lung cancer at earlier stages when the possibility of curative treatment is greater, and it is a proven method of reducing mortality [5] . LDCT’s effectiveness has been demonstrated in large randomized controlled trials, including the National Lung Screening Trial (NLST) in the United States and the Dutch-Belgian NELSON study [6] . Following pilot studies [6, 7], the UK National Screening Committee has recommended a national lung cancer screening program for high-risk individuals who use tobacco [8, 9] . In these trials, risk stratiﬁcation protocols have been used to select these individuals for screening [10, 11] . However, this approach restricts screening to those who are at  \nhigh risk due to lifestyle risk factors and does not consider all individuals (such as individuals who do not smoke) who may have an underlying susceptibility to lung cancer.  \nPolygenic scores (PGS) estimate the likelihood of developing a disease by aggregating the small, cumulative effects of single nucleotide polymorphisms (SNPs), typically identiﬁed through genome-wide association studies (GWAS) [12–15] . The increased availability of large-scale genetic datasets in the last 10 years has led to a considerable increase in the number of SNPs known to be associated with lung cancer development [16] . Several PGS have been developed for lung cancer, with moderate performance shown in some validation studies (C-index>0 .65) [14] . Howeve","cbCaihQbwubMg0yl","https://ap.wps.com/l/cbCaihQbwubMg0yl","pdf",502729,"English","# Introduction\n# Methods\n## Systematic review\n# Results\n# Discussion","[{\"question\":\"What question does the study address about lung cancer screening?\",\"answer\":\"It evaluates whether existing lung cancer polygenic scores can identify high-risk individuals in the general population, beyond tobacco-related risk stratification.\"},{\"question\":\"How were polygenic scores selected and validated?\",\"answer\":\"A systematic review identified published lung cancer PGS, which were implemented and validated in the UK Biobank cohort, with performance compared across scores.\"},{\"question\":\"What factors affected polygenic score performance?\",\"answer\":\"Subgroup analyses showed differences across sex, ethnicity, and smoking status, with many scores performing better in tobacco users than in non-users.\"}]","The current state of polygenic scores for the development of lung cancer: a systematic review and validation in UK Biobank | PDF",1790092873,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/009d3f47fcf6d2009b4a68883a4e4c4c.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/86bc6e4521cae136d5e9f5d89d06e1f1.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53dbda6bd34f3bd002cda07aa02d3afa.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f868694804e1da893cf342ae996641a.webp",980,1301]